Skip to main content
Caplight Logo









Inapill

Inapill

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.inapill.com/

Last Round

Pre Seed

Mar 1, 2024

Company Overview

Inapill is a biotechnology company developing first-in-class, orally available small molecule therapeutics that target immune cell metabolism to treat inflammatory and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunometabolismsmall molecule therapeuticsdrug discoverybiotech startuporal therapeuticsautoimmune disease treatmentinflammatory diseasemitochondrial functionpreclinical researchdrug pipelinebiopharmapharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inapill Comparables

Compare Inapill with similar companies based on industry and business-model similarity.

Inapill comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sitryx
84%
META Pharmaceuticals Inc.
82%
Rheos Medicines
81%

Inapill Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 1, 2024

Key People

Founding team and executive leadership

Greg Timblin

CEO & co-founder

Founding Team

Inapill Investors

Notable investors and investment history

Inapill investors
InvestorRounds
General InceptionPre Seed
California Life SciencesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2024

    Led by General Inception and California Life Sciences.

Inapill Filings

Explore SEC and related filing metadata, where available.

Inapill filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Inapill's valuation, stock price, and market status.

Is Inapill a public or private company?

Inapill is a private company.

What is the current stock price of Inapill?

Inapill is a private company with no public stock price. No recent secondary market data is available.

How much is Inapill worth (valuation)?

Valuation information for Inapill is not publicly available.

Can I buy Inapill stock?

Inapill shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Inapill's last funding round?

Inapill's most recent funding round was Pre Seed on March 1, 2024.

Who are the main investors in Inapill?

Key investors in Inapill include General Inception.

Will Inapill IPO soon?

No public IPO plans have been announced for Inapill.

How can I track Inapill secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inapill's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range3
Year Founded2021
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?